ConductScience.org, home

Paper42379802

Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells In Vitro.

Warmbold J and 2 others. In Vivo, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells In Vitro. Papers, record 42379802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42379802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells In Vitro.
PubMed
Journal
In Vivo
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Warmbold JJaqueline
2Gallwas JJulia
3Gründker CCarsten

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Plasminogen Activator Inhibitor 1Major topic
Carcinoma, Squamous CellMajor topic
Vulvar NeoplasmsMajor topic
Humans
Female
Cell Proliferation
Cell Movement
Cell Line, Tumor
Apoptosis
Cell Survival
Gene Expression Regulation, Neoplastic
Phenotype
Indoleacetic Acids

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112023852Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers.Biochem Soc Trans2002https://conductscience.org/library/papers/12023852PubMed
227154744GPER-novel membrane oestrogen receptor.Clin Sci (Lond)2016https://conductscience.org/library/papers/27154744PubMed
337762008Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells.Int J Mol Sci2023https://conductscience.org/library/papers/37762008PubMed
431846523Vulval squamous cell carcinoma and its precursors.Histopathology2020https://conductscience.org/library/papers/31846523PubMed
512784994Cell surface association of matrix metalloproteinase-9 (gelatinase B).Cancer Metastasis Rev2003https://conductscience.org/library/papers/12784994PubMed
639730177G Protein-coupled Estrogen Receptor 1 (GPER1) Regulates Expression of SERPINE1/PAI-1 and Inhibits Tumorigenic Potential of Cervical Squamous Cell Carcinoma Cells In Vitro.Cancer Genomics Proteomics2025https://conductscience.org/library/papers/39730177PubMed
739481051Advances in Vulvar Cancer Biology and Management.J Clin Oncol2025https://conductscience.org/library/papers/39481051PubMed
84357758In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.J Natl Cancer Inst1973https://conductscience.org/library/papers/4357758PubMed
912183417
Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).
Cancer Res2002https://conductscience.org/library/papers/12183417PubMed
1032960779Modern treatment of vulvar cancer.Radiol Oncol2020https://conductscience.org/library/papers/32960779PubMed
1138821614Clinical Impact of Pelvic Sentinel Lymph Node Biopsy for Vulvar Squamous Cell Carcinoma.Anticancer Res2024https://conductscience.org/library/papers/38821614PubMed
1215001579The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1.J Biol Chem2004https://conductscience.org/library/papers/15001579PubMed
1339543686A signaling pathway map of plasminogen activator inhibitor-1 (PAI-1/SERPINE-1): a review of an innovative frontier in molecular aging and cellular senescence.Cell Commun Signal2024https://conductscience.org/library/papers/39543686PubMed
1430419600The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive Role.Thromb Haemost2018https://conductscience.org/library/papers/30419600PubMed
1541658172Visualizing Cytoskeletal Protein Reconstruction of Vulvar Cancer with Surface-Enhanced Raman Spectroscopy and Gold Nanoparticles.ACS Omega2026https://conductscience.org/library/papers/41658172PubMed
1615386352Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.Int J Cancer2004https://conductscience.org/library/papers/15386352PubMed
1729980281Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.Gynecol Oncol2018https://conductscience.org/library/papers/29980281PubMed
1823097597Cell surface remodeling by plasmin: a new function for an old enzyme.J Biomed Biotechnol2012https://conductscience.org/library/papers/23097597PubMed
1935119068The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer.Clin Sci (Lond)2022https://conductscience.org/library/papers/35119068PubMed
2011266468The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies.J Cell Biol2001https://conductscience.org/library/papers/11266468PubMed

See all 35 referencesDownload CSV of references

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
GPER12852PubTator's text mininghttps://conductscience.org/library/genes/2852NCBI Gene
PLG5340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
SERPINE15054PubTator's text mininghttps://conductscience.org/library/genes/5054NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42379802

GET https://conductscience.org/api/papers/v1/42379802/references?page=2